Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis.

作者信息

Choueiri Toni K, Bauer Todd M, Papadopoulos Kyriakos P, Plimack Elizabeth R, Merchan Jaime R, McDermott David F, Michaelson M Dror, Appleman Leonard J, Thamake Sanjay, Perini Rodolfo F, Zojwalla Naseem J, Jonasch Eric

机构信息

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.

出版信息

Nat Med. 2021 Oct;27(10):1849. doi: 10.1038/s41591-021-01516-1.

DOI:10.1038/s41591-021-01516-1

PMID:34453144

Abstract

摘要

相似文献

[1]

Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis.

Nat Med. 2021-10

[2]

[Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof].

Zhonghua Yi Xue Za Zhi. 2006-6-13

[3]

The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.

Jpn J Clin Oncol. 2013-12-26

[4]

Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.

Hum Pathol. 2007-9

[5]

Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high mRNA levels in clear cell renal cell carcinoma.

J Biol Chem. 2019-1-7

[6]

Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.

Oncogene. 2000-11-16

[7]

Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.

Cancer Res. 2006-6-15

[8]

Allosteric inhibition of HIF-2α as a novel therapy for clear cell renal cell carcinoma.

Drug Discov Today. 2019-9-18

[9]

Hypoxia-Inducible Factor-2α as a Novel Target in Renal Cell Carcinoma.

J Kidney Cancer VHL. 2021-4-7

[10]

Expression of hypoxia-inducible factor 3α in hepatocellular carcinoma and its association with other hypoxia-inducible factors.

Exp Ther Med. 2016-6

引用本文的文献

[1]

The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5.

Sci Adv. 2025-6-20

[2]

Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells.

J Am Chem Soc. 2024-4-3

[3]

Belzutifan-induced regression of retinal capillary hemangioblastoma: A case-series.

Am J Ophthalmol Case Rep. 2024-2-10

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献